![Georgios Giamas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Georgios Giamas
Direktor/Vorstandsmitglied bei Stingray Bio Ltd.
Ursprung des Netzwerks ersten Grades von Georgios Giamas
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Stingray Bio Ltd.
![]() Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Stingray Bio Ltd. is a British biotechnology research company founded in 2020. The company is based in Brighton, UK. The company provides research services in the field of biotechnology.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Georgios Giamas
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
o2h Ltd
![]() o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Opal Therapeutics Ltd.
![]() Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opal Oncology Ltd. operates as a pharmaceutical company. It develops drugs for cancer. The company was founded in 2012 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
The Bioindustry Association
![]() The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Five Alarm Bio Ltd.
![]() Five Alarm Bio Ltd. Pharmaceuticals: MajorHealth Technology Five Alarm Bio Ltd. is a drug discovery firm that develops compounds that boost bodies’ ability to defend self against the damage of aging. It focuses on novel approaches to anti-aging, with broad potential therapeutic application. The company was founded by William Arthur Bains, Sunil Rajen Shah, and Ann Baker in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Alevin Therapeutics Ltd.
![]() Alevin Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Alevin Therapeutics Ltd. is a British company that focuses on developing safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies. The company is based in Cambridge, UK and was founded in 2022 by Chris Moody, Thomas McInally, Alison John. The company's preclinical pipeline features small molecules that target integrin receptors. | Miscellaneous Commercial Services | Chairman | |
Exonate Ltd.
![]() Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Medical/Nursing Services | Chairman | |
Oxford Drug Design Ltd.
![]() Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Director/Board Member | |
University of Cambridge | College/University | Masters Business Admin | |
Keele University | College/University | Undergraduate Degree | |
NeoPhore Ltd.
![]() NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Harvard Extension School | College/University | Undergraduate Degree | |
PhoreMost Ltd.
![]() PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer |
Statistik
International
Vereinigtes Königreich | 14 |
Vereinigte Staaten | 2 |
Sektoral
Health Technology | 4 |
Technology Services | 4 |
Commercial Services | 4 |
Consumer Services | 4 |
Finance | 2 |
Operativ
Director/Board Member | 10 |
Chief Executive Officer | 4 |
Founder | 4 |
Chairman | 3 |
Private Equity Investor | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Sunil Shah | 13 |
Jeffrey James Roix | 6 |
- Börse
- Insiders
- Georgios Giamas
- Unternehmensverbindungen